Daejeon, South Korea

Ho Jin Han

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ho Jin Han. Retrieved from https://idiyas.com/inventor/ho-jin-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ho Jin Han - Innovator in Anticancer Pharmaceutical Composition

Introduction

Ho Jin Han is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer properties. His work focuses on creating effective treatments with minimal side effects.

Latest Patents

Ho Jin Han holds a patent for a benzofuran-based N-acylhydrazone derivative. This innovative compound demonstrates an excellent anticancer effect while maintaining low toxicity and high solubility. The pharmaceutical composition comprising this derivative is particularly useful for preventing or treating cell proliferative disorders, including various types of cancer.

Career Highlights

Han is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts research aimed at advancing medical treatments. His dedication to improving cancer therapies has positioned him as a key figure in the pharmaceutical research community.

Collaborations

Some of his notable coworkers include Nak Kyun Soung and In Ja Ryoo, who contribute to the collaborative efforts in research and development within their institution.

Conclusion

Ho Jin Han's innovative work in developing anticancer pharmaceutical compositions highlights his commitment to advancing medical science. His contributions are paving the way for more effective cancer treatments with reduced side effects.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…